O-GlcNAc Antibody (HGAC85) - BSA Free

Western Blot: O-GlcNAc Antibody (HGAC85) [NB300-614] -

Western Blot: O-GlcNAc Antibody (HGAC85) [NB300-614] - AGO61 modifies GlcNAc residues at specific sites on alpha -DG.(a) alpha -DG-Fc was transiently transfected with or without AGO61 into COS1 cells. alpha -DG-Fc recombinant proteins were collected from cell lysates & culture media using protein A resin & analyzed for laminin overlay & Western blot using anti-Fc & anti-O-GlcNAc antibodies. (b) alpha -DG373-HALO & its mutant T317A/T319A were transiently transfected with or without LARGE-myc into COS7 cells. HALO-fused proteins were collected from medium using HALO resin followed by digestion with TEV protease & then analyzed by laminin overlay. Cell lysates were analyzed for the expression of HALO-fused proteins & LARGE-myc by Western blot using anti-HALO & anti-myc antibodies. The full-length blots with anti-HALO & anti-myc antibodies are presented in Supplementary Figs. S7f & S7g, respectively. (c) alpha -DG373-HALO & its mutant T317A/T319A were transiently transfected with or without AOG61 into COS7 cells. HALO-fused proteins were collected from the cell lysates using HALO resin followed by digestion with TEV protease & then analyzed by Western blot using an anti-O-GlcNAc antibody (CTD110.6). The cell lysates were analyzed for the expression of HALO-fused proteins & AGO61 by Western blot using anti-HALO & anti-AGO61 antibodies. The full-length blots with anti-HALO & anti-AGO61 antibodies are presented in Supplementary Figs. S7h & S7i, respectively. Image collected & cropped by CiteAb from the following publication (https://www.nature.com/articles/srep03288), licensed under a CC-BY license. Not internally tested by Novus Biologicals.